Exact Mass: 419.1544566

Exact Mass Matches: 419.1544566

Found 500 metabolites which its exact mass value is equals to given mass value 419.1544566, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Fenvalerate

alpha-Cyano-(3-phenoxyphenyl)methyl-4-chloro-alpha-(1-methylethyl)benzeneacetic acid

C25H22ClNO3 (419.1288132000001)

Agricultural, public health and animal husbandry insecticide.Fenvalerate is an insecticide. It is a mixture of four optical isomers which have different insecticidal activities. The 2-S alpha (or SS) configuration is the most insecticidally active isomer. Fenvalerate consists of about 23\\% of this isomer. (Wikipedia Agricultural, public health and animal husbandry insecticide Same as: D07952

jadomycin A

Jadomycin A; Jadomycin B aglycon

C24H21NO6 (419.13688060000004)

A organic heteropentacyclic compound that is 1,2,8,13-tetrahydro-3aH-benzo[b][1,3]oxazolo[3,2-f]phenanthridine which carries oxo groups at positions 2, 8 and 13, methyl group at position 5, hydroxy groups at positions 7 and 12, and a (2R)-butan-2-yl group at position 1. It is a mixture of epimers at the hemiaminal carbon (position 3a).

Esfenvalerate

C25H22ClNO3 (419.1288132000001)

D010575 - Pesticides > D007306 - Insecticides > D011722 - Pyrethrins D004791 - Enzyme Inhibitors D016573 - Agrochemicals

(14E)-2,11-dihydroxy-14-(1H-imidazol-5-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,13,16-triazatetracyclo[7.7.0.01,13.03,8]hexadeca-3,5,7,10-tetraene-12,15-dione

C22H21N5O4 (419.15934660000005)

(-)-3-(4-(2-(Phenoxazin-10-yl)ethoxy)phenyl)-2-ethoxypropanoic acid

C25H25NO5 (419.173264)

SCD1 Inhibitor

N-{4-[(2-methoxyethyl)(methyl)amino]phenyl}-2-phenyl-5-(trifluoromethyl)-1,3-oxazole-4-carboxamide

C21H20F3N3O3 (419.1456686)

Acorafloxacin

7-[3-(2-amino-1-fluoroethylidene)piperidin-1-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

C21H23F2N3O4 (419.1656542)

Dolutegravir

N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.0^{3,8}]tetradeca-10,13-diene-13-carboxamide

C20H19F2N3O5 (419.12927080000003)

Glycine, L-gamma-glutamyl-2-(1-methyl-4-(nitrosothio)-4-piperidinyl)glycyl-

2-Amino-4-({[(carboxymethyl)-C-hydroxycarbonimidoyl][1-methyl-4-(nitrososulphanyl)piperidin-4-yl]methyl}-C-hydroxycarbonimidoyl)butanoic acid

C15H25N5O7S (419.147462)

Perphenazine sulfoxide

2-chloro-10-{3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl}-10H-5lambda4-phenothiazin-5-one

C21H26ClN3O2S (419.1434166000001)

Styloguanidine

C17H22ClN9O2 (419.1584902)

Ancistrobenomine A

C25H25NO5 (419.173264)

5-[[1-[(4-hydroxyphenyl)methyl]-4-[(4-methoxyphenyl)methyl]imidazol-2-yl]amino]-3-methylimidazole-2,4-dione

C22H21N5O4 (419.15934660000005)

SCHEMBL10346729

C20H19F2N3O5 (419.12927080000003)

ethyl 2-[3-[[4-(4-methylphenyl)-1,3-thiazol-2-yl]methyl]-4-oxophthalazin-1-yl]acetate

C23H21N3O3S (419.13035560000003)

Glandicoline B

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-3-sulfanylpropanamido]-3-carbamoylpropanoic acid

C16H29N5O6S (419.18384540000005)

Leu Ala Asn Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]-3-carbamoylpropanamido]-3-sulfanylpropanoic acid

C16H29N5O6S (419.18384540000005)

Leu Cys Ala Asn

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-methylpentanamido]-3-sulfanylpropanamido]propanamido]-3-carbamoylpropanoic acid

C16H29N5O6S (419.18384540000005)

Leu Cys Gly Gln

(2S)-2-{2-[(2R)-2-[(2S)-2-amino-4-methylpentanamido]-3-sulfanylpropanamido]acetamido}-4-carbamoylbutanoic acid

C16H29N5O6S (419.18384540000005)

Leu Cys Asn Ala

(2S)-2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-methylpentanamido]-3-sulfanylpropanamido]-3-carbamoylpropanamido]propanoic acid

C16H29N5O6S (419.18384540000005)

Leu Cys Gln Gly

2-[(2S)-2-[(2R)-2-[(2S)-2-amino-4-methylpentanamido]-3-sulfanylpropanamido]-4-carbamoylbutanamido]acetic acid

C16H29N5O6S (419.18384540000005)

Leu Gly Cys Gln

(2S)-2-[(2R)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-3-sulfanylpropanamido]-4-carbamoylbutanoic acid

C16H29N5O6S (419.18384540000005)

Leu Gly Gln Cys

(2R)-2-[(2S)-2-{2-[(2S)-2-amino-4-methylpentanamido]acetamido}-4-carbamoylbutanamido]-3-sulfanylpropanoic acid

C16H29N5O6S (419.18384540000005)

Leu Asn Ala Cys

(2R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carbamoylpropanamido]propanamido]-3-sulfanylpropanoic acid

C16H29N5O6S (419.18384540000005)

Leu Asn Cys Ala

(2S)-2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-carbamoylpropanamido]-3-sulfanylpropanamido]propanoic acid

C16H29N5O6S (419.18384540000005)

Perphenazine sulfoxide

C21H26ClN3O2S (419.1434166000001)

7-Hydroxyperphenazine

C21H26ClN3O2S (419.1434166000001)

8-Hydroxy-perphenazine

C21H26ClN3O2S (419.1434166000001)

Leu Gln Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-carbamoylbutanamido]-3-sulfanylpropanamido]acetic acid

C16H29N5O6S (419.18384540000005)

Leu Gln Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-carbamoylbutanamido]acetamido}-3-sulfanylpropanoic acid

C16H29N5O6S (419.18384540000005)

Perphenazine-N-oxide

C21H26ClN3O2S (419.1434166000001)

Met Ala Ala Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]propanamido]propanamido]-4-carbamoylbutanoic acid

C16H29N5O6S (419.18384540000005)

Met Ala Gln Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]propanamido]-4-carbamoylbutanamido]propanoic acid

C16H29N5O6S (419.18384540000005)

Met Gly Asn Val

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}-3-carbamoylpropanamido]-3-methylbutanoic acid

C16H29N5O6S (419.18384540000005)

Asn Trp Thr

C19H25N5O6 (419.180475)

Met Gly Val Asn

(2S)-2-[(2S)-2-{2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]acetamido}-3-methylbutanamido]-3-carbamoylpropanoic acid

C16H29N5O6S (419.18384540000005)

Tyr Thr His

C19H25N5O6 (419.180475)

Met Asn Gly Val

(2S)-2-{2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]acetamido}-3-methylbutanoic acid

C16H29N5O6S (419.18384540000005)

Met Asn Val Gly

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-methylbutanamido]acetic acid

C16H29N5O6S (419.18384540000005)

2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-4-(methylsulfanyl)butanamido]-3-methylbutanamido]acetic acid

C16H29N5O6S (419.18384540000005)

Asn Pro Cys Ser

(2S)-2-[(2R)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-sulfanylpropanamido]-3-hydroxypropanoic acid

C15H25N5O7S (419.147462)

(2S)-2-[(2S)-3-carbamoyl-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]-3-hydroxypropanoic acid

C15H25N5O7S (419.147462)

Pro Cys Ser Asn

(2S)-3-carbamoyl-2-[(2S)-3-hydroxy-2-[(2R)-2-[(2S)-pyrrolidin-2-ylformamido]-3-sulfanylpropanamido]propanamido]propanoic acid

C15H25N5O7S (419.147462)

Thr Trp Asn

C19H25N5O6 (419.180475)

(2S)-2-[(2S,3R)-2-{2-[(2S)-2-amino-4-carbamoylbutanamido]acetamido}-3-hydroxybutanamido]butanedioic acid

C15H25N5O9 (419.16522)

Gln Ile Cys Gly

2-[(2R)-2-[(2S,3S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-methylpentanamido]-3-sulfanylpropanamido]acetic acid

C16H29N5O6S (419.18384540000005)

Ser Gln Trp

C16H29N5O6S (419.18384540000005)

Dolutegravir (GSK1349572)

C20H19F2N3O5 (419.12927080000003)

J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AJ - Integrase inhibitors D004791 - Enzyme Inhibitors > D019429 - Integrase Inhibitors > D019428 - HIV Integrase Inhibitors D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent

4-(tributylstannyl)quinoline

C21H33NSn (419.16348480000005)

METHYL 2-[(3-ETHOXYCARBONYL-PROPYL)-(TOLUENE-4-SULFONYL)-AMINO]-BENZOATE

C21H25NO6S (419.14025100000003)

(3R,4S)-3-Azetidinepropanoic acid,1-(4-fluorophenyl)-2-oxo-4[4(phenylmethoxy)phenyl]-methyl ester

C25H22FNO4 (419.15327840000003)

Fmoc-(S)-3-Amino-4-(2-fluoro-phenyl)-butyric acid

C25H22FNO4 (419.15327840000003)

2-Chloro-6-(diethylamino)-3-methylfluoran

C25H22ClNO3 (419.1288132000001)

VERALIPRIDE

C17H26ClN3O5S (419.12816160000006)

(S)-N-FMOC-alpha-Methyl-2-fluorophenylalanine

C25H22FNO4 (419.15327840000003)

Fmoc-(S)-3-Amino-4-(4-fluorophenyl)-butyric acid

C25H22FNO4 (419.15327840000003)

(R,R)-Fenvalerate

C25H22ClNO3 (419.1288132000001)

Fmoc-(R)-3-Amino-4-(2-fluorophenyl)-butyric acid

C25H22FNO4 (419.15327840000003)

(R)-FMOC-4-FLUORO-BETA-HOMOPHE-OH

C25H22FNO4 (419.15327840000003)

Fmoc-(S)-3-Amino-4-(3-fluorophenyl)-butyric acid

C25H22FNO4 (419.15327840000003)

Prazosin hydrochloride

C19H22ClN5O4 (419.13602420000007)

C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C72900 - Adrenergic Antagonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents Prazosin hydrochloride is a well-tolerated, CNS-active α1-adrenergic receptor antagonist for the research of high blood pressure and alcohol use disorders[1]. Prazosin hydrochloride potently inhibits Norepinephrine (NE)-stimulated 45Ca efflux with an IC50 of 0.15 nM[2].Prazosin hydrochloride inhibits organic cation transporters OCT-1 and OCT-3 with IC50s of 1.8, and 13 μM, respectively[3].

[4-[[3-chloro-4-[(2-cyanoethyl)amino]phenyl]azo]phenacyl]trimethylammonium chloride

C20H23Cl2N5O (419.1279568)

Norfloxacin Succinil

C20H22FN3O6 (419.1492564)

z-phe-pna

C23H21N3O5 (419.14811360000004)

N-(2-(3-(PIPERAZIN-1-YLMETHYL)IMIDAZO[2,1-B]THIAZOL-6-YL)PHENYL)PYRAZINE-2-CARBOXAMIDE

C21H21N7OS (419.15282160000004)

(3S,11aR)-6-methoxy-3-methyl-5,7-dioxo-2,3,5,7,11,11a-hexahydrooxazolo[3,2-d]pyrido[1,2-a]pyrazine-8-carboxylic acid

C20H19F2N3O5 (419.12927080000003)

Nampt-IN-1

C20H25N3O5S (419.15148400000004)

SCD1 inhibitor

N-(4-((2-Methoxyethyl)(methyl)amino)phenyl)-2-phenyl-5-(trifluoromethyl)oxazole-4-carboxamide

C21H20F3N3O3 (419.1456686)

Amoxicillin Trihydrate

C16H25N3O8S (419.136229)

A hydrate that is the trihydrate form of amoxicillin; a semisynthetic antibiotic, used either alone or in combination with potassium clavulanate (under the trade name Augmentin) for treatment of a variety of bacterial infections. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D010406 - Penicillins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

fmoc-(r)-3-amino-4-(3-fluoro-phenyl)-butyric acid

C25H22FNO4 (419.15327840000003)

CHIR-124

4-[(3s)-1-Azabicyclo[2.2.2]oct-3-Ylamino]-3-(1h-Benzimidazol-2-Yl)-6-Chloroquinolin-2(1h)-One

C23H22ClN5O (419.15127920000003)

Ac-Ala-Pro-Ala-pNA

C19H25N5O6 (419.180475)

Ragaglitazar

(-)-3-(4-(2-(Phenoxazin-10-yl)ethoxy)phenyl)-2-ethoxypropanoic acid

C25H25NO5 (419.173264)

C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist

(3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydrobenzo[g]indazole-7-carboxylic acid

C24H22ClN3O2 (419.14004620000003)

Bavisant dihydrochloride

C19H31Cl2N3O3 (419.1742356)

C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant Bavisant dihydrochloride hydrate (JNJ31001074AAC) is an orally active, potent, brain-penetrating and highly selective antagonist of the histamine H3 receptor. Bavisant dihydrochloride hydrate can be used for attention-deficit hyperactivity disorder (ADHD) research[1][2][3].

DolutegravirRRIsomer

C20H19F2N3O5 (419.12927080000003)

4-[(4-Fluorophenyl)-(6-hydroxy-2-methyl-5-thiazolo[3,2-b][1,2,4]triazolyl)methyl]-1-piperazinecarboxylic acid ethyl ester

C19H22FN5O3S (419.1427314)

Saxitoxin diacetate

C14H25N7O8 (419.176453)

4-(5-Benzenesulfonylamino-1-methyl-1H-benzoimidazol-2-ylmethyl)-benzamidine

C22H21N5O2S (419.14158860000003)

(1S,2R,5S)-5-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-A]pyrazin-7(8H)-YL]-2-(2,4,5-trifluorophenyl)cyclohexanamine

C18H19F6N5 (419.1544566)

(2r)-4-(2-Benzoyl-1,2-Diazepan-1-Yl)-4-Oxo-1-(2,4,5-Trifluorophenyl)butan-2-Amine

C22H24F3N3O2 (419.182052)

Fenvalerate

A N(6)-acyl-L-lysine arising from reductive N-alkylation of N(6)-acetyl-L-lysine by pyridoxal-5-phosphate.

deoxynivalenol 13-S-cysteine

C18H29NO8S (419.16137940000004)

Pydrin

Fenvalerate

C25H22ClNO3 (419.1288132000001)

D010575 - Pesticides > D007306 - Insecticides > D011722 - Pyrethrins D004791 - Enzyme Inhibitors D016573 - Agrochemicals Same as: D07952

ascofuranone(1-)

C23H28ClO5 (419.16251680000005)

A phenolate anion that is the conjugate base of ascofuranone resulting from the deprotonation of the 4-hydroxy group. Major species at pH 7.3.

ST 19:5;O6;Gly

C21H25NO8 (419.158009)

ST 20:5;O2;Tau

C22H29NO5S (419.17663440000007)

hnRNPK-IN-1

C23H21N3O5 (419.14811360000004)

hnRNPK-IN-1 is a heterogeneous nuclear ribonucleoprotein K (hnRNPK) binding ligand with Kd values of 4.6 μM and 2.6 μM measured with SPR and MST, respectively. hnRNPK-IN-1 inhibits c-myc transcription by disrupting the binding of hnRNPK and c-myc promoter. hnRNPK-IN-1 induces Hela cells apoptosis and has strongly anti-tumor activities[1].